Corporate Finance

Top execs from finance and tech join Relay Resources' board, bringing corporate power to accelerate its disability inclusion and social enterprise goals.

With strong revenue, key AI upgrades, and a top Microsoft award, Blue Yonder is solidifying its market lead as global supply chain pressures intensify.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

As energy markets face unprecedented volatility, a new platform promises radical transparency, challenging the opaque risk systems traders have long relied on.

A $50M deal with Master Investment Group will see Nauticus build a UAE hub, pushing the Emirates to the forefront of subsea automation.

A new 'zero-disruption' plate from TheWell Bioscience aims to solve key challenges in organoid research, promising more reliable data for drug discovery.

Amidst crypto market chaos, Empery Digital sells Bitcoin to repurchase shares and pay debt, signaling a major shift from 'HODL' to active management.

South Korean biotech Galux raises a major Series B round to accelerate its AI platform, which designs novel antibody drugs from scratch with high precision.

Safe Harbor Financial secures a landmark deal with PCCU, boosting revenue by $9M but taking on more risk. A bold move in the evolving cannabis finance world.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

Beverly Hills Plastic Surgery® is moving beyond aesthetics with its "Eternal G.L.O.W." series, a year-long program focused on holistic health.

New AI-powered 'Spend Control' platform with deep ERP integration aims to transform chaotic contract management into a strategic financial advantage for CFOs.

Bunker Hill Mining bets big with a C$30M capital raise and a drastic 1-for-35 reverse stock split, aiming for NYSE and full mine production.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

A landmark deal will see Takeda use Iambic's AI platform to slash drug development timelines and fast-track new medicines for cancer and other diseases.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.

Melius Research elevates 'AI eating software' visionary Ben Reitzes to Partner, signaling a major bet on tech-driven expansion for the independent firm.

As college costs soar, a new $1.5M initiative merges scholarships with financial literacy, aiming to reshape access and opportunity for students nationwide.